Lomitapide and Asciminib: Interaction Details
- Lomitapide
- Juxtapid
- Asciminib
- Scemblix
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Lomitapide and Asciminib interaction:
What Happens When You Take Lomitapide With Asciminib
What can happen when they are taken together (rated Major)
Increased lomitapide exposure and an increased risk of lomitapide-related adverse reactions
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Using asciminib together with lomitapide can raise lomitapide exposure and heighten the risk of adverse reactions. Asciminib 200 mg twice daily should not be combined with lomitapide.
For patients on a total asciminib dose of 80 mg/day, close monitoring is advised.2 With asciminib, the maximum recommended dosage (MRD) of lomitapide is 10 mg for ages 2 to 10 years, 20 mg for ages 11 to 17 years, and 30 mg for ages 18 years and older.
The schedule during depends on age. For ages 2 to 10 years, lomitapide goes from 2 mg (weeks 0 to 8) to 5 mg (weeks 9 to 12), then 10 mg (weeks 13 to 16), and 20 mg from week 17 onward; higher doses are not recommended.
For ages 11 to 15 years, titration starts at 2 mg (weeks 0 to 4), moves to 5 mg (weeks 5 to 8), 10 mg (weeks 9 to 12), and 20 mg (weeks 13 to 16), then 40 mg from week 17 onward; a 60 mg dose is not recommended. For ages 16 to 17 years, the steps are 2 mg (weeks 0 to 2), 5 mg (weeks 3 to 6), 10 mg (weeks 7 to 10), and 20 mg (weeks 11 to 14), then 40 mg from week 15 onward; a 60 mg dose is not recommended.
For ages 18 years and older, the titration follows the same pattern as for ages 16 to 17 years, but a 60 mg dose is permitted after week 15. When asciminib is started in a patient already on a stable lomitapide dose, the lomitapide dose should be halved.
Subsequent careful titration, guided by LDL-C response and safety/tolerability, may be considered up to half the MRD. The exception is coadministration with oral contraceptives only, where the lomitapide MRD is about two thirds of the MRD.1
The Lomitapide and Asciminib Interaction, Explained
Asciminib (Scemblix) can raise the amount of lomitapide (Juxtapid) in your body. It does this by slowing the liver enzyme () that normally breaks lomitapide down. More lomitapide can mean more side effects, such as stomach upset, diarrhea, and liver problems. This is a theoretical concern based on how the drugs work, but it is rated major, so it is taken seriously.
Your care team can manage this by adjusting your lomitapide dose and watching you more closely. Keep taking both exactly as prescribed, and talk with your pharmacist or doctor before changing anything. Let them know about any new stomach symptoms, or yellowing of your skin or eyes.
Mechanism: Asciminib is predicted to inhibit , reducing first-pass and systemic of lomitapide (a sensitive CYP3A4 ). Expected result is increased lomitapide exposure (/) and a greater risk of adverse reactions, including toxicity and (transaminase elevation, fat). Lomitapide is not a . Evidence is theoretical; severity is major; onset is unspecified.
- Avoid lomitapide with asciminib 200 mg twice daily.
- Monitor closely if the asciminib total dose is 80 mg/day.
- Lomitapide MRD with asciminib: 10 mg (ages 2 to 10), 20 mg (11 to 17), 30 mg (18 and older). Follow the labeled age-based schedules.
- If starting asciminib in a patient on stable lomitapide, reduce the lomitapide dose by half. Then titrate carefully to LDL-C response and tolerability, up to half the MRD (about two thirds of the MRD with oral contraceptives only).
See the 2 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Lomitapide and Asciminib Interact
The likely mechanism
of -mediated of lomitapide
How to Manage the Lomitapide and Asciminib Interaction
Your care team can usually manage this by tailoring your lomitapide dose and monitoring you more closely.
- If you are already on a stable lomitapide dose when asciminib is started, the lomitapide dose is typically cut in half. It may then be increased carefully based on your LDL cholesterol response and how well you tolerate it.
- Lomitapide has a maximum dose when used with asciminib, and the limit depends on age.
- Asciminib 200 mg twice daily should be avoided with lomitapide.
- If you take asciminib 80 mg/day total, expect closer monitoring.
Keep taking both as prescribed, and tell your pharmacist or prescriber about any new symptoms or medicines. Do not change doses on your own.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Lomitapide or Asciminib need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
2 reports from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Prescribing information: SCEMBLIX oral tablets, asciminib oral tablets
When asciminib 40 mg twice daily was given together with midazolam (a ), the (inf) of midazolam rose by 28% and its rose by 11%. With asciminib 80 mg once daily, midazolam AUC(inf) and Cmax were increased by 24% and 17%, respectively. With asciminib 200 mg twice daily, the increases in midazolam AUC(inf) and Cmax were 88% and 58%, respectively.2
-
Report 2 · Study title
Prescribing information: JUXTAPID oral capsules, lomitapide oral capsules
of atorvastatin (a weak ) 80 mg daily with a single 20 mg dose of lomitapide produced a 2-fold increase in lomitapide and a 2.1-fold increase in , relative to lomitapide given alone.1
Lomitapide and Asciminib: Common Questions
How serious is the Lomitapide and Asciminib interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Lomitapide and Asciminib interaction managed?
Your care team can usually manage this by tailoring your lomitapide dose and monitoring you more closely. If you are already on a stable lomitapide dose when asciminib is started, the lomitapide dose is typically cut in half. It may then be increased carefully based on your LDL cholesterol response and how well you tolerate it. Lomitapide has a maximum dose when used with asciminib, and the limit… Management is individual — always follow your own care team's guidance.
Does taking Lomitapide and Asciminib at different times of day help?
No. Taking them at different times of day does not prevent this one. Asciminib slows , an enzyme that breaks down lomitapide, so lomitapide can build up in the body. That change lasts while asciminib is being taken and can continue for a while after the last dose.
Your pharmacist or prescriber can tell you how they will manage it.
Who is at higher risk from the Lomitapide and Asciminib interaction?
The interaction record names this group as more likely to be affected:
- People taking higher doses
If this describes you, tell your pharmacist or prescriber.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Lomitapide and Asciminib Interaction
Ask in your own words about taking Lomitapide and Asciminib together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (2)
Other Serious Interactions of Lomitapide and Asciminib
Also serious with Lomitapide
- Ketoconazole TopicalContraindicated
- LefamulinContraindicated
- Lenacapavir OralContraindicated
- Letermovir InjectionContraindicated
Also serious with Asciminib
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Lomitapide
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- WineMajor
- BeerMajor
- Siberian CockleburMajor
- Vitamin EModerate
- Vitamin AModerate
- + 164 more
With Asciminib
- Activated CharcoalMajor
- Slippery ElmModerate
- CannabisModerate
- YohimbeModerate
- GlucomannanModerate
- AdrafinilModerate
- Cannabidiol (CBD)Moderate
- Cannabinol (CBN)Moderate
- + 23 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.